Genomics in Scotland strategy: business and regulatory impact assessment
Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).
12. Enforcement, Sanctions, and Monitoring
The strategy does not propose regulations or legislation therefore enforcement and sanctions will not be required. Scottish Government and the SSNGM will work with Health Boards to implement the actions in the strategy and accompanying action plans. As part of delivery, we will also develop a set of performance measures to monitor and report on both the implementation of the strategy and the overall delivery of genomic medicine services in Scotland.
Contact
Email: holly.ennis@gov.scot
There is a problem
Thanks for your feedback